|
May 21
|
3 Cash-Producing Stocks in Hot Water
|
|
May 20
|
S&P 500 Gains and Losses Today: FICO Stock Falls as Federal Housing Official Questions Pricing
|
|
May 20
|
Regeneron Pharmaceuticals (NasdaqGS:REGN) Partners With Viz.ai For AI-Powered COPD Solutions
|
|
May 20
|
ATS 2025: Sanofi and Regeneron to launch new AIM4 trial for personalised asthma care
|
|
May 20
|
Evercore says 23andMe buyout removes downside case for OraSure
|
|
May 20
|
REGN Signs $256M Buyout Deal With 23andMe to Boost Genomics Research
|
|
May 20
|
Jamie Dimon’s Tariffs Warning Should Have Rocked Markets. Why He’s Being Ignored.
|
|
May 19
|
Regeneron to acquire bankrupt genetic tester 23andMe
|
|
May 19
|
Regeneron to Buy 23andMe Out of Bankruptcy for $256 Million
|
|
May 19
|
Regeneron Buys 23andMe in Bankruptcy Auction
|
|
May 9
|
Jim Cramer on Regeneron Pharmaceuticals, Inc. (REGN): ‘Numbers Came Up A Little Short’
|
|
May 9
|
1 Cash-Heavy Stock on Our Buy List and 2 to Ignore
|
|
May 8
|
Regeneron Pharmaceuticals, Inc. (REGN): Among the Cheap ESG Stocks to Buy According to Hedge Funds
|
|
May 7
|
Regeneron Pharmaceuticals (REGN): Among Billionaire Mario Gabelli’s Large-Cap Stock Picks with Huge Upside Potential
|
|
Apr 22
|
Regeneron to Report Q1 Earnings: What's in Store for the Stock?
|
|
Apr 22
|
Regeneron Pharmaceuticals (NasdaqGS:REGN) Expands U.S. Capacity With US$3 Billion Fujifilm Partnership
|
|
Apr 22
|
Eli Lilly, Vertex, AbbVie, and More Pharma Stocks to Own as Tariffs Loom
|
|
Apr 22
|
Regeneron partners with Fujifilm to broaden manufacturing capacity
|
|
Apr 22
|
Analysts Estimate Regeneron (REGN) to Report a Decline in Earnings: What to Look Out for
|
|
Apr 22
|
Drug Companies Step Up 'Make in America' Plans to Counter Tariffs
|